- Home
- SQFT vs INDP Comparison
SQFT vs INDP Comparison
Compare SQFT & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQFT
- INDP
- Stock Information
- Founded
- SQFT 1999
- INDP 2000
- Country
- SQFT United States
- INDP United States
- Employees
- SQFT N/A
- INDP N/A
- Industry
- SQFT Real Estate Investment Trusts
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- SQFT Real Estate
- INDP Health Care
- Exchange
- SQFT Nasdaq
- INDP Nasdaq
- Market Cap
- SQFT 6.2M
- INDP 6.0M
- IPO Year
- SQFT 2020
- INDP N/A
- Fundamental
- Price
- SQFT $5.15
- INDP $12.00
- Analyst Decision
- SQFT
- INDP Strong Buy
- Analyst Count
- SQFT 0
- INDP 2
- Target Price
- SQFT N/A
- INDP $238.00
- AVG Volume (30 Days)
- SQFT 12.4K
- INDP 698.6K
- Earning Date
- SQFT 08-13-2025
- INDP 08-11-2025
- Dividend Yield
- SQFT N/A
- INDP N/A
- EPS Growth
- SQFT N/A
- INDP N/A
- EPS
- SQFT N/A
- INDP N/A
- Revenue
- SQFT $18,260,398.00
- INDP N/A
- Revenue This Year
- SQFT $23.63
- INDP N/A
- Revenue Next Year
- SQFT N/A
- INDP N/A
- P/E Ratio
- SQFT N/A
- INDP N/A
- Revenue Growth
- SQFT N/A
- INDP N/A
- 52 Week Low
- SQFT $4.19
- INDP $7.56
- 52 Week High
- SQFT $8.77
- INDP $66.64
- Technical
- Relative Strength Index (RSI)
- SQFT 51.05
- INDP 53.68
- Support Level
- SQFT $4.55
- INDP $9.45
- Resistance Level
- SQFT $5.77
- INDP $13.40
- Average True Range (ATR)
- SQFT 0.37
- INDP 2.17
- MACD
- SQFT 0.09
- INDP 0.20
- Stochastic Oscillator
- SQFT 56.96
- INDP 29.39
About SQFT Presidio Property Trust Inc.
Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.